BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12818717)

  • 1. The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats.
    Ciccocioppo R; Economidou D; Fedeli A; Massi M
    Physiol Behav; 2003 Jun; 79(1):121-8. PubMed ID: 12818717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of Nociceptin/Orphanin FQ and Dynorphin Systems in the Extended Amygdala of Alcohol Preferring Marchigian Sardinian (msP) Rats.
    Caputi FF; Stopponi S; Rullo L; Palmisano M; Ubaldi M; Candeletti S; Ciccocioppo R; Romualdi P
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat.
    Economidou D; Hansson AC; Weiss F; Terasmaa A; Sommer WH; Cippitelli A; Fedeli A; Martin-Fardon R; Massi M; Ciccocioppo R; Heilig M
    Biol Psychiatry; 2008 Aug; 64(3):211-8. PubMed ID: 18367152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic intracerebroventricular infusion of nociceptin/orphanin FQ increases food and ethanol intake in alcohol-preferring rats.
    Cifani C; Guerrini R; Massi M; Polidori C
    Peptides; 2006 Nov; 27(11):2803-10. PubMed ID: 16730389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats.
    Ciccocioppo R; Polidori C; Antonelli L; Salvadori S; Guerrini R; Massi M
    Peptides; 2002 Jan; 23(1):117-25. PubMed ID: 11814626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the rat.
    Ciccocioppo R; Stopponi S; Economidou D; Kuriyama M; Kinoshita H; Heilig M; Roberto M; Weiss F; Teshima K
    Neuropsychopharmacology; 2014 Oct; 39(11):2601-10. PubMed ID: 24863033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats.
    Ciccocioppo R; Economidou D; Fedeli A; Angeletti S; Weiss F; Heilig M; Massi M
    Psychopharmacology (Berl); 2004 Mar; 172(2):170-8. PubMed ID: 14624331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOP receptor antagonism attenuates reinstatement of alcohol-seeking through modulation of the mesolimbic circuitry in male and female alcohol-preferring rats.
    Borruto AM; Fotio Y; Stopponi S; Petrella M; De Carlo S; Domi A; Ubaldi M; Weiss F; Ciccocioppo R
    Neuropsychopharmacology; 2021 Nov; 46(12):2121-2131. PubMed ID: 34285372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system.
    Ciccocioppo R; Economidou D; Rimondini R; Sommer W; Massi M; Heilig M
    Biol Psychiatry; 2007 Jan; 61(1):4-12. PubMed ID: 16533497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats.
    de Guglielmo G; Martin-Fardon R; Teshima K; Ciccocioppo R; Weiss F
    Addict Biol; 2015 Jul; 20(4):643-51. PubMed ID: 24930632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal.
    Aujla H; Cannarsa R; Romualdi P; Ciccocioppo R; Martin-Fardon R; Weiss F
    Addict Biol; 2013 May; 18(3):467-79. PubMed ID: 22804785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
    Zaveri NT
    Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats.
    Economidou D; Fedeli A; Fardon RM; Weiss F; Massi M; Ciccocioppo R
    Peptides; 2006 Dec; 27(12):3299-306. PubMed ID: 17097763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rostromedial tegmental nucleus nociceptin/orphanin FQ (N/OFQ) signaling regulates anxiety- and depression-like behaviors in alcohol withdrawn rats.
    Li W; Ren Z; Tang Y; Fu Y; Sun S; Ding R; Hou J; Mai Y; Zhan B; Zhu Y; Zuo W; Ye JH; Fu R
    Neuropsychopharmacology; 2023 May; 48(6):908-919. PubMed ID: 36329156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area.
    Borruto AM; Fotio Y; Stopponi S; Brunori G; Petrella M; Caputi FF; Romualdi P; Candeletti S; Narendran R; Rorick-Kehn LM; Ubaldi M; Weiss F; Ciccocioppo R
    Br J Pharmacol; 2020 Apr; 177(7):1525-1537. PubMed ID: 31713848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
    Gavioli EC; Calo' G
    Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ORL-1 (NOP1) receptor ligand nociceptin/orphanin FQ (N/OFQ) inhibits neurogenic dural vasodilatation in the rat.
    Bartsch T; Akerman S; Goadsby PJ
    Neuropharmacology; 2002 Nov; 43(6):991-8. PubMed ID: 12423668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nphe(1)]N/OFQ-(1-13)-NH(2) is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K(+) channel activation in rat periaqueductal gray slices.
    Chiou LC; Fan SH; Guerrini R; Caló G
    Neuropharmacology; 2002 Feb; 42(2):246-52. PubMed ID: 11804621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.